Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Operating Income (2018 - 2025)

Historic Operating Income for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $5.6 million.

  • Viemed Healthcare's Operating Income rose 24.88% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 2564.98%. This contributed to the annual value of $17.9 million for FY2024, which is 2491.28% up from last year.
  • Viemed Healthcare's Operating Income amounted to $5.6 million in Q3 2025, which was up 24.88% from $5.1 million recorded in Q2 2025.
  • Viemed Healthcare's 5-year Operating Income high stood at $6.5 million for Q4 2024, and its period low was $1.0 million during Q2 2022.
  • For the 5-year period, Viemed Healthcare's Operating Income averaged around $3.5 million, with its median value being $3.5 million (2022).
  • Its Operating Income has fluctuated over the past 5 years, first tumbled by 7928.3% in 2021, then skyrocketed by 18981.02% in 2023.
  • Over the past 5 years, Viemed Healthcare's Operating Income (Quarter) stood at $4.7 million in 2021, then fell by 24.24% to $3.5 million in 2022, then skyrocketed by 49.66% to $5.3 million in 2023, then increased by 21.99% to $6.5 million in 2024, then decreased by 12.55% to $5.6 million in 2025.
  • Its Operating Income was $5.6 million in Q3 2025, compared to $5.1 million in Q2 2025 and $3.8 million in Q1 2025.